Table 3.

Clinicopathological features among vitiligo patients.

Variable	Cases (n = 85)
Skin type
Type I	1 (1.2%)
Type II	21 (24.7%)
Type III	42 (49.4%)
Type IV	17 (20%)
Type V	4 (4.7%)
Premature graying of hair
No	59 (69.4%)
Yes	26 (30.6%)
Duration of disease
≤ 1 year	14 (16.5%)
1–5 years	24 (28.2%)
> 5–10 years	22 (25.9%)
> 10 years	25 (29.4%)
Trichrome
No	64 (75.3%)
Yes	21 (24.7%)
Hypopigmentation
No	16 (18.8%)
Yes	69 (81.2%)
Follicular re-pigmentation
No	55 (64.7%)
Yes	30 (35.3%)
Koebner’s phenomena
No	16 (18.8%)
Yes	69 (81.2%)
VIDA
Stage -1	33 (39.3%)
Stage 0	3 (3.6%)
Stage 1	11 (13.1%)
Stage 2	16 (19%)
Stage 3	18 (21.4%)
Stage 4	2 (2.4%)
VASI	0.5 ± 0.03

Data are shown as number (percentage). VASI vitiligo area severity index, VIDA vitiligo disease activity.